Jazz Pharmaceuticals Total Assets 2007-2019 | JAZZ

Jazz Pharmaceuticals total assets from 2007 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Jazz Pharmaceuticals total assets for the quarter ending March 31, 2019 were $5.280B, a 0.13% decline year-over-year.
  • Jazz Pharmaceuticals total assets for 2018 were $5.203B, a 1.56% increase from 2017.
  • Jazz Pharmaceuticals total assets for 2017 were $5.124B, a 6.74% increase from 2016.
  • Jazz Pharmaceuticals total assets for 2016 were $4.8B, a 44.04% increase from 2015.
Jazz Pharmaceuticals Annual Total Assets
(Millions of US $)
2018 $5,203
2017 $5,124
2016 $4,800
2015 $3,333
2014 $3,339
2013 $2,238
2012 $1,966
2011 $254
2010 $136
2009 $107
2008 $117
2007 $208
2006 $215
2005 $0
Jazz Pharmaceuticals Quarterly Total Assets
(Millions of US $)
Q1 2019 $5,280
Q4 2018 $5,203
Q3 2018 $5,486
Q2 2018 $5,349
Q1 2018 $5,287
Q4 2017 $5,124
Q3 2017 $4,999
Q2 2017 $4,804
Q1 2017 $4,816
Q4 2016 $4,800
Q3 2016 $4,931
Q2 2016 $3,448
Q1 2016 $3,535
Q4 2015 $3,333
Q3 2015 $3,464
Q2 2015 $3,393
Q1 2015 $3,238
Q4 2014 $3,339
Q3 2014 $3,348
Q2 2014 $3,156
Q1 2014 $3,196
Q4 2013 $2,238
Q3 2013 $2,185
Q2 2013 $2,094
Q1 2013 $2,010
Q4 2012 $1,966
Q3 2012 $1,727
Q2 2012 $1,698
Q1 2012 $895
Q4 2011 $254
Q3 2011 $208
Q2 2011 $193
Q1 2011 $154
Q4 2010 $136
Q3 2010 $108
Q2 2010 $97
Q1 2010 $107
Q4 2009 $107
Q3 2009 $102
Q2 2009 $109
Q1 2009 $110
Q4 2008 $117
Q3 2008 $180
Q2 2008 $187
Q1 2008 $239
Q4 2007 $208
Q3 2007 $259
Q2 2007 $277
Q1 2007 $0
Q4 2006 $0
Q3 2006 $0
Q2 2006 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.885B $1.891B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $48.809B 31.18
Takeda Pharmaceutical (TAK) Japan $27.294B 10.10
Grifols (GRFS) Spain $12.617B 15.96
Ionis Pharmaceuticals (IONS) United States $9.458B 20.67
Sage Therapeutics (SAGE) United States $8.591B 0.00
Neurocrine Biosciences (NBIX) United States $7.214B 0.00
Catalent (CTLT) United States $6.611B 26.53
Nektar Therapeutics (NKTR) United States $5.581B 9.10
Tilray (TLRY) Canada $4.419B 0.00
United Therapeutics (UTHR) United States $3.971B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.964B 12.76
FibroGen (FGEN) United States $3.082B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.560B 9.22
PTC Therapeutics (PTCT) United States $2.275B 0.00
Portola Pharmaceuticals (PTLA) United States $2.013B 0.00
Xencor (XNCR) United States $1.931B 52.72
Arrowhead Pharmaceuticals (ARWR) United States $1.845B 278.00
Pacira Pharmaceuticals (PCRX) United States $1.806B 87.46
Aerie Pharmaceuticals (AERI) United States $1.794B 0.00
Tricida (TCDA) United States $1.772B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.771B 24.20
USANA Health Sciences (USNA) United States $1.763B 15.32
Ironwood Pharmaceuticals (IRWD) United States $1.741B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.590B 0.00
Zogenix (ZGNX) United States $1.587B 0.00
Endo (ENDP) Ireland $1.475B 2.37
Heron Therapeutics (HRTX) United States $1.430B 0.00
Esperion Therapeutics (ESPR) United States $1.392B 0.00
Corcept Therapeutics (CORT) United States $1.247B 17.80
Theravance Biopharma (TBPH) Cayman Islands $1.158B 0.00
TURNING PT THER (TPTX) United States $1.016B 0.00
Radius Health (RDUS) United States $0.971B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.924B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.809B 0.00
TherapeuticsMD (TXMD) United States $0.803B 0.00
ArQule (ARQL) United States $0.741B 0.00
ChemoCentryx (CCXI) United States $0.722B 0.00
Aptorum Group (APM) China $0.716B 0.00
Akebia Therapeutics (AKBA) United States $0.648B 0.00
ORGANOGENESIS (ORGO) United States $0.636B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.632B 0.00
CannTrust Holdings (CTST) Canada $0.632B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.604B 0.00
Odonate Therapeutics (ODT) United States $0.597B 0.00
Dermira (DERM) United States $0.564B 0.00
GlycoMimetics (GLYC) United States $0.535B 0.00
Translate Bio (TBIO) United States $0.510B 0.00
Flexion Therapeutics (FLXN) United States $0.476B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.468B 23.65
Corbus Pharmaceuticals Holdings (CRBP) United States $0.456B 0.00
Siga Technologies (SIGA) United States $0.452B 1.06
Collegium Pharmaceutical (COLL) United States $0.418B 0.00
Mast Therapeutics (SVRA) United States $0.411B 0.00
KalVista Pharmaceuticals (KALV) United States $0.410B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.390B 0.00
OptiNose (OPTN) United States $0.378B 0.00
Forty Seven (FTSV) United States $0.378B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.359B 0.00
TCR2 Therapeutics (TCRR) United States $0.337B 0.00
Xeris Pharmaceuticals (XERS) United States $0.334B 0.00
ImmunoGen (IMGN) United States $0.307B 0.00
Dova Pharmaceuticals (DOVA) United States $0.304B 0.00
CASI Pharmaceuticals (CASI) United States $0.302B 0.00
Karyopharm Therapeutics (KPTI) United States $0.282B 0.00
Harpoon Therapeutics (HARP) United States $0.279B 0.00
Molecular Templates (MTEM) United States $0.275B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.261B 0.00
Concert Pharmaceuticals (CNCE) United States $0.252B 0.00
Aratana Therapeutics (PETX) United States $0.239B 0.00
MEI Pharma (MEIP) United States $0.237B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.237B 0.00
Lannett Co Inc (LCI) United States $0.236B 2.29
Aclaris Therapeutics (ACRS) United States $0.233B 0.00
Minerva Neurosciences (NERV) United States $0.231B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.229B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.226B 0.00
Calithera Biosciences (CALA) United States $0.221B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.221B 0.00
Galectin Therapeutics (GALT) United States $0.207B 0.00
Aldeyra Therapeutics (ALDX) United States $0.201B 0.00
Recro Pharma (REPH) United States $0.199B 0.00
Opexa Therapeutics (ACER) United States $0.193B 0.00
IMV INC (IMV) Canada $0.191B 0.00
Majesco Entertainment (PTE) United States $0.189B 0.00
Ardelyx (ARDX) United States $0.187B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 59.06
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.169B 0.00
Redhill Biopharma (RDHL) Israel $0.168B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.166B 0.00
Jounce Therapeutics (JNCE) United States $0.161B 0.00
Tyme Technologies (TYME) United States $0.152B 0.00
Ocular Therapeutix (OCUL) United States $0.148B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.148B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.145B 0.00
Neon Therapeutics (NTGN) United States $0.144B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.135B 0.00
Aquestive Therapeutics (AQST) United States $0.126B 0.00
Bio Blast Pharma (ENLV) Israel $0.124B 0.00
DURECT (DRRX) United States $0.121B 0.00
MediWound (MDWD) Israel $0.121B 0.00
Nivalis Therapeutics (ALPN) United States $0.111B 0.00
ProNAi Therapeutics (SRRA) Canada $0.109B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.101B 72.22
Cardiome Pharma (CORV) Canada $0.100B 0.00
Iterum Therapeutics (ITRM) Ireland $0.099B 0.00
Champions Oncology (CSBR) United States $0.099B 0.00
China SXT Pharmaceuticals (SXTC) China $0.099B 0.00
Natural Alternatives (NAII) United States $0.097B 9.67
Zafgen (ZFGN) United States $0.093B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.090B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.087B 0.00
Otonomy (OTIC) United States $0.086B 0.00
Neos Therapeutics (NEOS) United States $0.085B 0.00
Infinity Pharmaceuticals (INFI) United States $0.084B 0.00
Adherex Technologies (FENC) United States $0.081B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Avenue Therapeutics (ATXI) United States $0.078B 0.00
SCYNEXIS (SCYX) United States $0.077B 0.00
Capnia (SLNO) United States $0.062B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.049B 0.00
AIT Therapeutics (AITB) Israel $0.047B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
CTI BioPharma (CTIC) United States $0.046B 0.00
Lipocine (LPCN) United States $0.046B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Bio-Path Holdings (BPTH) United States $0.044B 0.00
Novan (NOVN) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
BioLineRx (BLRX) Israel $0.041B 0.00
ContraFect (CFRX) United States $0.039B 0.00
KemPharm (KMPH) United States $0.038B 0.00
Melinta Therapeutics (MLNT) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Citius Pharmaceuticals (CTXR) United States $0.030B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
HANCOCK JAFFE (HJLI) United States $0.027B 0.00
Achieve Life Sciences (ACHV) United States $0.024B 0.00
Regulus Therapeutics (RGLS) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.022B 2.93
PharmAthene (ALT) United States $0.022B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Shineco (TYHT) China $0.019B 3.11
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
Trillium Therapeutics (TRIL) Canada $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.97
VAXART, INC (VXRT) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.007B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00